Aclarion (ACON) Competitors $5.11 -0.16 (-3.04%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$4.84 -0.27 (-5.28%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends ACON vs. KDLY, BGLC, OTRK, SSY, DHAC, VSEE, ATIP, ATPC, NIVF, and BACKShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Kindly MD (KDLY), BioNexus Gene Lab (BGLC), Ontrak (OTRK), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), Vsee Health (VSEE), ATI Physical Therapy (ATIP), Agape ATP (ATPC), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry. Aclarion vs. Kindly MD BioNexus Gene Lab Ontrak SunLink Health Systems Digital Health Acquisition Vsee Health ATI Physical Therapy Agape ATP NewGenIvf Group IMAC Aclarion (NASDAQ:ACON) and Kindly MD (NASDAQ:KDLY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, institutional ownership, risk and profitability. Do analysts prefer ACON or KDLY? Aclarion presently has a consensus price target of $435.50, indicating a potential upside of 8,422.50%. Given Aclarion's stronger consensus rating and higher probable upside, equities analysts plainly believe Aclarion is more favorable than Kindly MD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Kindly MD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer ACON or KDLY? Aclarion received 4 more outperform votes than Kindly MD when rated by MarketBeat users. CompanyUnderperformOutperformAclarionOutperform Votes480.00% Underperform Votes120.00% Kindly MDN/AN/A Does the media prefer ACON or KDLY? In the previous week, Aclarion had 2 more articles in the media than Kindly MD. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for Kindly MD. Aclarion's average media sentiment score of 0.00 equaled Kindly MD'saverage media sentiment score. Company Overall Sentiment Aclarion Neutral Kindly MD Neutral Do insiders and institutionals believe in ACON or KDLY? 7.5% of Aclarion shares are owned by institutional investors. 0.8% of Aclarion shares are owned by company insiders. Comparatively, 50.5% of Kindly MD shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has preferable earnings & valuation, ACON or KDLY? Kindly MD has higher revenue and earnings than Aclarion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$80K32.58-$4.91MN/AN/AKindly MD$2.88M4.91N/AN/AN/A Is ACON or KDLY more profitable? Kindly MD has a net margin of 0.00% compared to Aclarion's net margin of -12,845.05%. Kindly MD's return on equity of 0.00% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets Aclarion-12,845.05% -422.87% -201.15% Kindly MD N/A N/A N/A SummaryAclarion beats Kindly MD on 7 of the 12 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACON vs. The Competition Export to ExcelMetricAclarionMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.61M$3.12B$5.81B$9.02BDividend YieldN/A20.51%4.77%3.84%P/E RatioN/A12.1521.5016.68Price / Sales32.58169.12453.1985.13Price / CashN/A385.9743.9637.32Price / Book-0.044.847.654.65Net Income-$4.91M-$22.21M$3.18B$245.69M7 Day Performance13.56%-4.33%-1.95%-2.67%1 Month PerformanceN/A-2.39%-0.23%-2.16%1 Year Performance-98.75%13.74%16.69%12.90% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONAclarion2.2025 of 5 stars$5.11-3.0%$435.50+8,422.5%-99.0%$2.61M$80,000.000.007Gap DownKDLYKindly MDN/A$1.26+1.1%N/AN/A$7.49MN/A0.00N/ABGLCBioNexus Gene LabN/A$0.38-1.3%N/A-53.2%$6.83M$9.77M0.0030OTRKOntrak3.1583 of 5 stars$1.62-0.9%$45.00+2,686.4%-49.4%$6.82M$12.74M-0.15250Analyst RevisionNews CoverageSSYSunLink Health SystemsN/A$0.93+0.5%N/A+18.5%$6.51M$32.44M-8.411,376Analyst ForecastGap UpDHACDigital Health AcquisitionN/A$1.76+0.6%N/A-84.6%$6.34MN/A0.002,021High Trading VolumeVSEEVsee HealthN/A$1.75-0.9%N/AN/A$6.28MN/A0.00N/AATIPATI Physical TherapyN/A$1.02-1.0%N/A-84.4%$4.50M$699.02M-0.055,600Upcoming EarningsNews CoverageATPCAgape ATPN/A$1.02-19.6%N/A-86.6%$4.13M$1.43M-1.4240NIVFNewGenIvf Group2.2875 of 5 stars$0.13-6.7%N/AN/A$1.24M$5.14M0.00N/ANews CoverageGap UpHigh Trading VolumeBACKIMACN/A$0.55-8.2%N/A-58.1%$1.12M$16.19M0.00180News CoverageGap Up Related Companies and Tools Related Companies Kindly MD Competitors BioNexus Gene Lab Competitors Ontrak Competitors SunLink Health Systems Competitors Digital Health Acquisition Competitors Vsee Health Competitors ATI Physical Therapy Competitors Agape ATP Competitors NewGenIvf Group Competitors IMAC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACON) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
